SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Procter&Gamble Healt - Quaterly Results

09 Feb 2022 Evaluate
The company witnessed a 15.69% growth in the revenue at Rs. 2779.00 millions for the quarter ended December 2021 as compared to Rs. 2402.20 millions during the year-ago period.A big decline of -33.94% was reported for the quarter ended December 2021 to Rs. 448.40  millions from Rs. 678.80 millions of corresponding previous quarter.A decline of 665.40 millions was observed in the OP in the quarter ended December 2021 from 944.70 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202112 202012 % Var 202112 202012 % Var 202106 202006 % Var
Sales 2779.00 2402.20 15.69 5507.00 5041.90 9.22 10087.30 8911.96 13.19
Other Income 47.00 57.20 -17.83 77.40 124.40 -37.78 181.00 337.27 -46.33
PBIDT 665.40 944.70 -29.56 1476.50 1792.90 -17.65 2641.20 2444.80 8.03
Interest 1.20 1.90 -36.84 2.60 4.30 -39.53 8.00 0.00 0.00
PBDT 664.20 942.80 -29.55 1473.90 1788.60 -17.59 2633.20 2444.80 7.71
Depreciation 65.90 78.50 -16.05 134.90 152.10 -11.31 300.40 206.18 45.70
PBT 598.30 864.30 -30.78 1339.00 1636.50 -18.18 2332.80 2238.62 4.21
TAX 149.90 185.50 -19.19 336.90 365.10 -7.72 564.80 545.70 3.50
Deferred Tax 1.00 -4.80 -120.83 -5.00 -14.10 -64.54 -49.00 94.90 -151.63
PAT 448.40 678.80 -33.94 1002.10 1271.40 -21.18 1768.00 1692.92 4.43
Equity 166.00 166.00 0.00 166.00 166.00 0.00 166.00 166.00 0.00
PBIDTM(%) 23.94 39.33 -39.12 26.81 35.56 -24.60 26.18 27.43 -4.55

Procter&Gamble Healt Share Price

5021.30 29.00 (0.58%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×